UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
G G0 G1 G2 G3 G4 GA GB GC GD GE GF GG GH GI GL GM GN GO GP GQ GR GS GT GU GV GW GX GY GZ G%
GP GP1 GP2 GPA GPD GPI GPM GPO GPP GPR GPT GPX
selected terms: 88 page 1 of 1

1. G protein
[family of small membrane-bound proteins which, in the presence of GTP/GDP, transduce signals from receptor to effector molecules across the membrane; do not use for other guanine nucleotide binding proteins. ( CSP )] (UMLS (CSP) C0086376) =Amino Acid, Peptide, or Protein; Enzyme ;
=guanine nucleotide binding protein;
=transducin;
exchange factor;
45. gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-2/MART-1 Antigen
(UMLS (NCI) C0796634) gp100/IFA/IL-2/MART-1 =Therapeutic or Preventive Procedure
2. G protein coupled receptor
[Cell surface receptors that are coupled to G-proteins (GTP-binding protein). G-protein coupled receptors are thought to have seven membrane spanning domains and have been divided into 2 subclasses: those in which the binding site is in the extracellular domain for example receptors for glycoprotein hormones, such as thyroid stimulating hormone (TSH) and follicle-stimulating hormone (FSH) and those in which the ligand binding site is likely to be in the plane of the 7 transmembrane domains for example rhodopsin and receptors for small neurotransmitters and hormones for example muscarinic acetylcholine receptor. ( NCI )] (UMLS (CSP) C0682972) =Amino Acid, Peptide, or Protein; Receptor
46. gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-2/MART-1 Antigen/Tyrosinase Peptide
(UMLS (NCI) C0677811) =Therapeutic or Preventive Procedure
3. G protein coupled receptor kinase
[serine and threonine protein kinases that specifically recognize activated G protein coupled receptor proteins. ( CSP )] (UMLS (CSP) C0872043) =Amino Acid, Peptide, or Protein; Enzyme =EC 2.7.1.37;
47. gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen
(UMLS (NCI) C0796633) gp100/IFA/MART-1 =Therapeutic or Preventive Procedure
4. G Protein Gene
[Classification. Proto-oncogenes that code for G proteins. ( NCI )] (UMLS (NCI) C0812324) Proto-Oncogene, G-Protein;
=Gene or Genome ;
48. gp100 Antigen/Incomplete Freund's Adjuvant/MART-1 Antigen/Tyrosinase Peptide
(UMLS (NCI) C0677810) =Therapeutic or Preventive Procedure
5. G Protein Pathway Suppressor 1 Gene
[This gene is involved in suppression of signal transduction. ( NCI )] (UMLS (NCI) C1333702) GPS1;
GPS1 Gene =Gene or Genome
49. gp100 Antigen/Incomplete Freund's Adjuvant/Sargramostim/Tyrosinase Peptide
(UMLS (NCI) C0796681) =Therapeutic or Preventive Procedure
6. G Protein Pathway Suppressor 2
[G Protein Pathway Suppressor 2 Protein (GPS2), encoded by the GPS2 gene, are two distinct protein isoforms from specified transcript variants. In budding yeast, GPS is a suppressor of lethal G-protein subunit-activating mutations in the pheromone response pathway. In mammalian cells, GPS2 has been shown to suppress RAS- and mitogen-activated protein kinase-mediated signaling and interfere c-Jun N-terminal Kinase activation. GPS2 is also involved in transcriptional activation of papillomavirus genes through its interaction with virus E2 and E6 proteins. (from LocusLink) ( NCI )] (UMLS (NCI) C0533630) =Amino Acid, Peptide, or Protein; Biologically Active Substance
50. gp100 Antigen/Incomplete Freund's Adjuvant/Tyrosinase Peptide
(UMLS (NCI) C0678070) =Therapeutic or Preventive Procedure ;
7. G Protein Pathway Suppressor 2 Gene
[This gene plays a role in suppression of signal transduction. ( NCI )] (UMLS (NCI) C1333703) GPS2;
GPS2 Gene =Gene or Genome
51. gp100 Antigen/Interferon Alfa/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide
(UMLS (NCI) C0935703) =Therapeutic or Preventive Procedure
8. G Protein, Beta-2 Subunit
[Expressed in oocytes and blastocysts by human GNB2 Gene, 340-aa 37-kDa Guanine Nucleotide Binding Protein Beta 2 is a heterotrimeric G protein beta subunit with 7 WD repeats and involved in transmembrane signaling as a transducer that regulates G protein alpha subunits and integrates signals between receptors and effector proteins. The G protein beta and gamma subunits are required for GTPase activity, for GTP replacement of GDP, and for G protein/effector interaction. (NCI) ( NCI )] (UMLS (NCI) C1333885) GNB2;
Guanine Nucleotide Binding Protein Beta 2;
Guanine Nucleotide-Binding Protein G(I)/G(S)/G(T) Beta Subunit 2;
Signal-Transducing Guanine Nucleotide-Binding Regulatory Protein Beta Subunit;
Transducin Beta Chain 2;
=Amino Acid, Peptide, or Protein; Biologically Active Substance
52. gp100 Antigen/Interferon Alfa/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide
(UMLS (NCI) C0935704) =Therapeutic or Preventive Procedure
9. G Protein, Beta-3 Subunit
[Encoded by human GNB3 Gene, 340-aa 37-kDa Guanine Nucleotide Binding Protein Beta 3 is a heterotrimeric G protein beta subunit with 7 WD repeats and involved in transmembrane signaling as a transducer that regulates G protein alpha subunits and integrates signals between receptors and effector proteins. The G protein beta and gamma subunits are required for GTPase activity, for GTP replacement of GDP, and for G protein/effector interaction. A splicing polymorphism is associated with essential hypertension and obesity. ( NCI )] (UMLS (NCI) C1122941) GNB3;
GTP-Binding Regulatory Protein Beta-3 Chain;
Guanine Nucleotide Binding Protein Beta 3;
Guanine Nucleotide-Binding Protein G(I)/G(S)/G(T) Beta Subunit 3;
Transducin Beta Chain 3 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
53. gp100 Antigen/Interleukin-12/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide
(UMLS (NCI) C1134585) =Therapeutic or Preventive Procedure ;
10. G Protein-Coupled Receptor 109B Gene
[This gene is involved in G protein-coupled receptor signal transduction and nicotinic acid receptor activity. ( NCI )] (UMLS (NCI) C1333902) GPR109B;
GPR109B Gene =Gene or Genome ;
54. gp100 Antigen/Interleukin-12/Montanide ISA-51
(UMLS (NCI) C0879318) =Therapeutic or Preventive Procedure
11. G Protein-Coupled Receptor 17
[G Protein-Coupled Receptor 17, encoded by the GPR17 gene, is a putative receptor for purines coupled to G-proteins. Two alternative products are primarily expressed in brain. This Integral membrane protein belongs to family 1 of G-protein coupled receptors. (from Swiss-Prot and OMIM) ( NCI )] (UMLS (NCI) C1333731) GPR17;
P2Y-Like Receptor;
Probable P2Y Purinoceptor GPR17;
R12 =Amino Acid, Peptide, or Protein; Receptor
55. gp100 Antigen/Interleukin-12/Montanide ISA-51/Tyrosinase Peptide
(UMLS (NCI) C0879306) =Therapeutic or Preventive Procedure
12. G Protein-Coupled Receptor 17 Gene
[This gene is involved in G protein-coupled receptor signal transduction but an exact function is not known. ( NCI )] (UMLS (NCI) C1333691) GPR17;
GPR17 Gene;
=Gene or Genome
56. gp100 Antigen/Interleukin-2
(UMLS (NCI) C0281723) =Therapeutic or Preventive Procedure
13. G Protein-Coupled Receptor 32
[Encoded by human GPR32 Gene (GPCR1 Family), 356-aa 40-kDa integral membrane protein G Protein-Coupled Receptor 32 is an orphan receptor with greatest similarity to chemoattractant receptors, particularly the formylpeptide receptor (FPR1). (NCI) ( NCI )] (UMLS (NCI) C0757496) GPR32;
Probable G Protein-Coupled Receptor GPR32;
=Amino Acid, Peptide, or Protein; Receptor ;
57. gp100 Antigen/interleukin-2/MART-1 Antigen
(UMLS (NCI) C0392986) =Therapeutic or Preventive Procedure
14. G Protein-Coupled Receptor 32 Gene
[This gene is involved in G protein-coupled receptor signal transduction. ( NCI )] (UMLS (NCI) C1333693) GPR32;
GPR32 Gene =Gene or Genome
58. gp100 Antigen/Interleukin-2/MART-1 Antigen/Montanide ISA-51
(UMLS (NCI) C0879299) =Therapeutic or Preventive Procedure
15. G Protein-Coupled Receptor 39
[Widely expressed by human GPR39 Gene (GPCR1 Family), 453-aa 51-kDa 7-transmembrane orphan G Protein-Coupled Receptor 39 exhibits high homology to the growth hormone secretagogue receptor (GHSR). (NCI) ( NCI )] (UMLS (NCI) C1333733) GPR39;
Putative G Protein-Coupled Receptor GPR39 =Amino Acid, Peptide, or Protein; Receptor
59. gp100 Antigen/Interleukin-2/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide
(UMLS (NCI) C0879325) =Therapeutic or Preventive Procedure
16. G Protein-Coupled Receptor 39 Gene
[This gene is involved in G protein-coupled receptor signal transduction and the regulation of growth factor release. ( NCI )] (UMLS (NCI) C1333694) GPR39;
GPR39 Gene =Gene or Genome
60. gp100 Antigen/Interleukin-2/Montanide ISA-51
(UMLS (NCI) C0879311) =Therapeutic or Preventive Procedure
17. G Protein-Coupled Receptor 54
[Encoded by human GPR54 Gene, 395-aa 43-kDa G Protein-Coupled Receptor 54 is a Gq/11-coupled receptor for endogenous KISS1 (Metastin), which appears to inhibit chemotaxis. (NCI) ( NCI )] (UMLS (NCI) C1097812) G Protein-Coupled Receptor AXOR12;
GPR54;
G-Protein-Coupled Receptor GPR54;
Metastin Receptor;
=Amino Acid, Peptide, or Protein; Receptor ;
61. gp100 Antigen/Interleukin-2/Montanide ISA-51/Tumor Infiltrating Lymphocytes
(UMLS (NCI) C0879363) =Therapeutic or Preventive Procedure ;
18. G Protein-Coupled Receptor 54 Gene
[This gene plays a role in G protein-coupled receptor signal transduction and is associated with thyroid carcinoma. ( NCI )] (UMLS (NCI) C1333695) GPR54;
GPR54 Gene =Gene or Genome
62. gp100 Antigen/MAGE-3/MART-1 Antigen/Tyrosinase Peptide
(UMLS (NCI) C0796513) =Therapeutic or Preventive Procedure
19. G Protein-Coupled Receptor 68
[G Protein-Coupled Receptor 68, encoded by the GPR68 gene, belongs to family 1 of G-protein coupled receptors. This integral membrane protein is a receptor for sphingosylphosphorylcholine and couples to G proteins that stimulate phosphoinositide hydrolysis. It acts as a proton-sensing receptor stimulating inositol phosphate formation and is involved in pH homeostasis. The skeleton participates in pH homeostasis as a buffering organ and osteoblasts respond to pH changes in the physiologic range. This receptor represents an osteoblastic pH sensor regulating cell-mediated responses to acidosis in bone. (from Swiss-Prot and OMIM) ( NCI )] (UMLS (NCI) C1259265) GPR68;
OGR-1;
Ovarian Cancer G Protein-Coupled Receptor 1;
Sphingosylphosphorylcholine Receptor;
=Amino Acid, Peptide, or Protein; Receptor ;
63. gp100 Antigen/MART-1 Antigen
(UMLS (NCI) C0392993) =Therapeutic or Preventive Procedure
20. G Protein-Coupled Receptor 68 Gene
[This gene is involved in G protein-coupled receptor signal transduction and pH homeostasis. ( NCI )] (UMLS (NCI) C1333696) GPR68;
GPR68 Gene =Gene or Genome
64. gp100 Antigen/MART-1 Antigen/Montanide ISA-51
(UMLS (NCI) C0879298) =Therapeutic or Preventive Procedure
21. G Protein-Coupled Receptor Gene
[These genes encodes G protein-coupled receptors (GPRs or GPCRs). GPRs contain 7 hydrophobic transmembrane domains embedded in hydrophilic intra- and extracellular loops and transduce a variety of hormone, endogenous peptide, and neurotransmitter signals into intracellular effects via G proteins. (from OMIM 604161) ( NCI )] (UMLS (NCI) C1367690) GPCR;
GPR =Gene or Genome
65. gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide
(UMLS (NCI) C0879326) =Therapeutic or Preventive Procedure
22. G Protein-Coupled Receptor Kinase 1 Gene
[This gene is involved in sensory transduction necessary for vision. ( NCI )] (UMLS (NCI) C1335620) GRK1;
GRK1 Gene =Gene or Genome ;
66. gp100 Antigen/MART-1 Antigen/Montanide ISA-51/Tyrosinase Peptide
(UMLS (NCI) C0879324) =Therapeutic or Preventive Procedure
23. G Protein-Coupled Receptor Kinase 1B
[Encoded by human RHOK Gene (GPRK Family), 563-aa 64-kDa membrane-bound Rhodopsin Kinase, containing 1 RGS domain, regulates GPCR rhodopsin desensitization and initiates rhodopsin deactivation by phosphorylation following light stimulation. (NCI) ( NCI )] (UMLS (NCI) C1384522) GRK1;
Rhodopsin Kinase;
RHOK;
RK;
=Amino Acid, Peptide, or Protein; Enzyme
67. gp100 Antigen/MART-1 Antigen/Tyrosinase Peptide
(UMLS (NCI) C0879342) =Therapeutic or Preventive Procedure
24. G Protein-Coupled Receptor Kinase 4 Gene
[This gene is involved in signal transduction. ( NCI )] (UMLS (NCI) C1333698) GRK4;
GRK4 Gene =Gene or Genome
68. gp100 Antigen/Montanide ISA-51
(UMLS (NCI) C0879313) =Therapeutic or Preventive Procedure
25. G Protein-Coupled Receptor Kinase 5 Gene
[This gene plays a role in signal transduction and the regulation of polymorphonuclear leukocyte motility. ( NCI )] (UMLS (NCI) C1333699) GRK5;
GRK5 Gene =Gene or Genome
69. gp100 Antigen/Montanide ISA-51/Sargramostim
(UMLS (NCI) C0879319) =Therapeutic or Preventive Procedure
26. G Protein-Coupled Receptor Kinase 6 Gene
[This gene is involved in signal transduction. ( NCI )] (UMLS (NCI) C1333700) GRK6;
GRK6 Gene =Gene or Genome
70. gp100 Antigen/Montanide ISA-51/Sargramostim/Tetanus Peptide Melanoma Vaccine/Tyrosinase Peptide
(UMLS (NCI) C0879307) =Therapeutic or Preventive Procedure
27. G Protein-Coupled Receptor Kinase 7 Gene
[This gene plays a role in signal transduction within the retina. ( NCI )] (UMLS (NCI) C1333701) GRK7;
GRK7 Gene =Gene or Genome
71. gp100 Antigen/Montanide ISA-51/Sargramostim/Tyrosinase Peptide
(UMLS (NCI) C0879329) =Therapeutic or Preventive Procedure
28. G Protein-Coupled Receptor Kinase Gene
[G Protein-Coupled Receptor Kinase Genes encode G Protein-Coupled Receptor Kinases, which regulate through phosphorylation the signaling function of G protein-coupled receptors and signal transduction. (NCI) ( NCI )] (UMLS (NCI) C1333739) =Gene or Genome ;
72. gp100 Antigen/Montanide ISA-51/Tyrosinase Peptide
(UMLS (NCI) C0879297) =Therapeutic or Preventive Procedure
29. G Protein-Coupled Receptor Kinase Interactor 1 Gene
[This gene plays a role in signal transduction and cytoskeletal remodeling. ( NCI )] (UMLS (NCI) C1333676) GIT1;
GIT1 Gene =Gene or Genome ;
73. gp100 Antigen/QS21/Tyrosinase Peptide
(UMLS (NCI) C0678089) =Therapeutic or Preventive Procedure
30. G Protein-Coupled Receptor Kinase Interactor 2 Gene
[This gene is involved in signal transduction and regulation of receptor signaling. ( NCI )] (UMLS (NCI) C1333677) GIT2;
GIT2 Gene;
=Gene or Genome ;
74. gp100 Antigen/Sargramostim/Tyrosinase Peptide
(UMLS (NCI) C0678090) =Therapeutic or Preventive Procedure
31. G Protein-Coupled Receptor Kinase-Interactor 1
[G Protein-Coupled Receptor Kinase-Interactor 1: GIT1 is a multidomain protein that is thought to function as an integrator of signaling pathways controlling vesicle trafficking, adhesion and cytoskeletal organization. (from J Cell Sci 2002 Apr 1;115(Pt 7):1497-510) ( NCI )] (UMLS (NCI) C1333736) GIT1;
=Amino Acid, Peptide, or Protein; Biologically Active Substance
75. gp100 Antigen/Tetanus Peptide Melanoma Vaccine/Tyrosinase Peptide
(UMLS (NCI) C0879347) =Therapeutic or Preventive Procedure
32. G Protein-Coupled Receptor, Family C, Group 5, Member C
[Expressed in stomach, kidney, liver, lung, pancreas, central nervous system, and prostate by human GPRC5C Gene (GPCRc Family), 441-aa 48-kDa 7-transmembrane G Protein-Coupled Receptor Family C Group 5 Member C has an extracellular N-terminal domain, an intracellular C-terminal domain, and conserved cysteines residues. The specific protein function is unknown; it may mediate retinoic acid effects on G protein signal transduction. (NCI) ( NCI )] (UMLS (NCI) C0963060) GPRC5C;
Orphan G-Protein Coupled Receptor;
Retinoic Acid Responsive Gene Protein;
=Amino Acid, Peptide, or Protein; Receptor ;
76. gp100 Antigen/Tyrosinase Peptide
(UMLS (NCI) C0678047) =Therapeutic or Preventive Procedure ;
33. G Protein-Coupled Receptor, Family C, Group 5, Member C Gene
[This gene plays a role in G protein-coupled receptor signal transduction but the specific function of this protein is unknown. ( NCI )] (UMLS (NCI) C1333697) GPRC5C;
GPRC5C Gene =Gene or Genome
77. gp120
[glycoprotein encoded by HIV envelope gene (env) with a molecular weight of 120,000; interaction between gp120 and CD4 on T-helper cells is involved in the recognition of the cells by HIV and the binding of HIV to those cells. ( CSP )] (UMLS (CSP) C0019691) =Amino Acid, Peptide, or Protein; Biologically Active Substance =HIV envelope protein;
34. G15 Protein
[Widely expressed by human RBM5 Gene, 815-aa 92-kDa RNA Binding Motif Protein 5 contains 2 RRM domains, a G-patch domain, and a RANBP2-type zinc finger and specifically binds to RNA. (NCI) ( NCI )] (UMLS (NCI) C0907884) Putative Tumor Suppressor LUCA15;
RNA Binding Motif Protein 5;
RNA-Binding Protein 5 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
78. GP145-TRKC
[Widely expressed (mainly nervous tissue) by human NTRK3 Gene (IR Tyr Kinase Family) as alternative isoforms A (839-aa 94-kDa precursor), B (612-aa), C (825-aa), and D (830-aa), Neurotrophic Tyrosine Kinase Receptor Type 3 is a type I membrane receptor for NTF3 containing 2 LRR repeats and 2 Ig-like C2-type domains. Monomeric (low affinity) and dimeric (high affinity) forms appear to exist in dynamic equilibrium and the isoforms do not have identical signaling properties. Known substrates for TRK receptors are SHC, PI-3 kinase, and PLC-gamma-1. NTRK3 undergoes ligand-mediated auto-phosphorylation. (NCI) ( NCI )] (UMLS (NCI) C0132300) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
35. G22P1
[This gene is involved in DNA repair and DNA metabolic processes. ( NCI )] (UMLS (NCI) C1333651) G22P1 Gene;
Thyroid Autoantigen 70kDa (Ku Antigen) Gene;
=Gene or Genome ;
79. gp160
[glycoprotein encoded by HIV envelope gene (env) with a molecular weight of 160,000 daltons. ( CSP )] (UMLS (CSP) C0062790) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=HIV envelope protein;
36. G6PD
[This gene plays a role in carbohydrate metabolism. ( NCI )] (UMLS (NCI) C1333652) G6PD Gene;
Glucose-6-Phosphate Dehydrogenase Gene;
=Gene or Genome ;
80. gp209-2M Antigen/Heat Shock Protein 70/OVA Bip Peptide/Tyrosinase Peptide
(UMLS (NCI) C0879488) =Therapeutic or Preventive Procedure
37. G6PD deficiency
[common hereditary enzyme deficiency causing varying degrees of hemolytic anemia; can cause favism, some drug induced hemolytic anemias, and chronic nonspherocytic hemolytic anemia. ( CSP )] (UMLS (CSP) C0017920) =Disease or Syndrome =ANEMIA HEMOLITIKOA;
glycogen storage disease;
Congenital Metabolic Disorder;
enzyme deficiency
81. gp209-2M Antigen/Incomplete Freund's Adjuvant/Interleukin-2
(UMLS (NCI) C0796405) gp209-2M/IFA/IL-2;
=Therapeutic or Preventive Procedure
38. gp 330
[An LDL-RECEPTOR RELATED PROTEIN found in the neuroepithelium and in proximal tubular cells of the kidney. It is considered a multiligand receptor in that it binds to a variety of ligands with relatively high affinity and may function in mediating the uptake and lysosomal degradation of macromolecules such as: LIPOPROTEINS; ENDOPEPTIDASES; and PROTEASE INHIBITORS. ( MSH )] (UMLS (CSP) C0284555) =Amino Acid, Peptide, or Protein; Receptor ;
82. gp209-2M Antigen/Interleukin-2/Montanide ISA-51
(UMLS (NCI) C0879596) =Therapeutic or Preventive Procedure
39. gp100 Antigen with Incomplete Freund's Adjuvant
(UMLS (NCI) C0338206) =Therapeutic or Preventive Procedure
83. GPI-0100
[A semi-synthetic triterpene glycoside, derived from the naturally occurring saponins. GPI-0100 functions as an adjuvant when given as part of a vaccine preparation to improve the immunogenicity of antigens such as proteins, carbohydrates. GPI-0100 containing vaccines have been used with both viral and tumor antigens to elicit a Type 1 helper T cell response for those diseases in which a cytotoxic T lymphocyte (CTL) response is desired. ( NCI )] (UMLS (NCI) C0935831) =Carbohydrate; Pharmacologic Substance ;
40. gp100 Antigen/HPV-16 E7(12-20) Peptide Vaccine/Montanide ISA-51
(UMLS (NCI) C0879304) =Therapeutic or Preventive Procedure
84. GPI-0100/MUC-2-Globo H-KLH Conjugate Vaccine
(UMLS (NCI) C0935833) =Therapeutic or Preventive Procedure
41. gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12
(UMLS (NCI) C0392984) =Therapeutic or Preventive Procedure
85. GPOH-HD 95 Regimen
[A regimen consisting of vincristine, prednisone, procarbazine and doxorubicin (OPPA) used in combination with radiation therapy for the treatment of female patients with low-risk, childhood Hodgkin's lymphoma. ( NCI )] (UMLS (NCI) C0134006) =Therapeutic or Preventive Procedure ;
42. gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/MART-1 Antigen/Tyrosinase Peptide
(UMLS (NCI) C0677816) =Therapeutic or Preventive Procedure
86. GPR
[Rod-shaped bacteria that retain the crystal violet stain when treated by Gram's method. ( NCI )] (UMLS (NCI) C0085498) =Bacterium
43. gp100 Antigen/Incomplete Freund's Adjuvant/Interleukin-12/Tyrosinase Peptide
(UMLS (NCI) C0678069) =Therapeutic or Preventive Procedure ;
87. GPRC5A
[Encoded by human RAI3 Gene (GPCR3 Family), 357-aa 40-kDa Retinoic Acid Induced 3 protein contains 7 predicted GPCR-signature transmembrane domains and a potential N-linked glycosylation site. Likely involved in the interaction between retinoid acid and G protein signaling pathways, RAI3 may play a role in embryonic development and epithelial cell differentiation. (NCI) ( NCI )] (UMLS (NCI) C0762318) RAI3;
RAIG1;
Retinoic Acid Induced 3 =Amino Acid, Peptide, or Protein; Receptor
44. gp100 Antigen/Incomplete Freund's Adjuvant/interleukin-2
(UMLS (NCI) C0392983) =Therapeutic or Preventive Procedure
88. GPX-100
[An anticancer drug that belongs to the family of drugs called antitumor antibiotics. It is an anthracycline. ( NCI )] (UMLS (NCI) C0796383) =Organic Chemical; Antibiotic

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM